Thrivent Financial For Lutherans Nova Bay Pharmaceuticals, Inc. Transaction History

Thrivent Financial For Lutherans

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$2.9 - $4.65 $3,712 - $5,952	-1,280 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.0 - $4.75 $5,120 - $6,080	1,280	1,280 $6,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.8M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.